A commitment to increasing access to cancer care has driven Icon Group beyond Australian shores to embrace opportunities in the ASEAN region. With the incorporation of Singapore Oncology Consultants [SOC] providing a solid foundation on which to build a strong regional presence, we continue to explore new opportunities across South-East Asia and into China furthering the Group’s vision to make an impact on the global cancer burden. Our current portfolio includes:
Cancer Services – Asia
A commitment to increasing access to cancer care has driven Icon Group beyond Australian shores to embrace opportunities in the ASEAN region.
The Group’s Icon Cancer Centres in Singapore were formed with the introduction of Singapore Oncology Consultants [SOC]– a private oncology provider who have been delivering care in Singapore since 2006.
Guided by this prominent and strong cohort of doctors, our seven Icon Cancer Centres across Singapore treats thousands of patients every year. Further to our commitment across Singapore we continue to provide more care to surrounding regions with outreach clinics into Vietnam and Myanmar. In addition to treating Singaporeans, Icon cares for patients from surrounding countries who travel for a personalised, holistic approach to cancer care. As a result, we have become a regional hub acknowledged for evidence-based treatments and a supportive approach to patient care.
Our shared-care model allows patients flexible and portable methods of treatment. This ensures the organisation is well positioned to face emerging trends in cancer care and local Asian industry influences.
Since acquisition, our Singapore arm has significantly grown their footprint from seven to 12 clinicians. Hand-in-hand with this has been a growth in clinics from four to seven, with the acquisition of Haematology Oncology Clinic – the first private haematology group in Singapore – rounding out this number in the last year.
Together with this growth, the last twelve months have been focused on service evolution, introducing both haematology and radiation oncology services in 2018. Across our Singapore centres we currently partners with hospitals to deliver radiation oncology services to ensure patients receive comprehensive care by a multidisciplinary team.
In June 2019 Icon was appointed to build and manage a new state-of-the-art integrated cancer centre at Mount Alvernia Hospital that will bring together medical oncology, haematology and radiation oncology. Icon’s global partnership with Varian Medical Systems will see this centre become the regional training hub for radiation oncologists, medical physicists and radiation therapists in the Asia-Pacific region.
In January 2017 Icon signed a Commissioning and Operational Management Service Agreement for cancer centres to be built with Chengde Chong Yuan Investment Group Co. Ltd. This agreement will see Icon Group managing design, construction and commissioning of Chengde Chong Yuan Investment Group’s cancer centres. Icon will also deliver clinical operational management as part of the partnership, this will include training, education, technical expertise and quality assurance to ensure the residents of Chengde and surrounding areas receive world-class cancer care. Over the next two years the cancer burden in China will increase by 70% and this partnership will bring Australian expertise and cutting-edge techniques to the people of China to help address this burden.
In February 2019, Icon Group signed a milestone agreement with China’s Sanbo Brain Hospital Management Group to deliver radiation oncology services. These services are set to open late 2019 in their Chag’an hospital in Chongqing. We are excited about the potential China based projects in discussion and look forward to rolling out further services in the coming months.
In early 2018 Icon Group also signed a milestone agreement at the ASEAN-Australia Summit to deliver cancer care infrastructure and technology in Vietnam. Vietnam faces a growing burden of cancer with an expected 70% increase in diagnoses over the next two decades and without the number of oncology treatment facilities and workforce capacity, this demand for cancer treatment will not be met.
This agreement will see Icon collaborate with two of Vietnam’s leading healthcare providers – The National Cancer Hospital in Hanoi [the K Hospital] and the Military 175 Hospital in Ho Chi Minh City. Icon skills and capabilities will develop large scale cancer care infrastructure, implement an international standard in medical excellence across hospital management, and leverage innovative technologies to deliver remote care where it is needed. Experts from Icon Group’s Australian and Singaporean businesses will be critical in supporting Vietnamese health providers to meet demand while building local capacity for the future. Icon will begin to implement services in Vietnam as early as mid 2018.